Cited by 4,649Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, Lawrence A., Harvey, Michele, Slagle, Betty L., McArthur, Mark J., Montgomery, Charles A., Butel, Janet S., Bradley, Allan·1992·Nature

DOI 10.1038/356215a0

Open this paper in CoChat — free account

Abstract

Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.

Integrity signals

Registry

Crossref · 10.1038/356215a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997
Self-citation
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 10

Mowat, M., Cheng, A., Kicumca, N., Bernstein, A. & Benchimol, S. Nature 61, 2777–2781 (1985).
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S. & Bernstein, A. Oncogene 3, 179–185 (1988).
Stürzbecher, H.-W. et al. Oncogene 5, 795–801 (1990).
Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. Oncogene 5, 1707–1711 (1990).
Soussi, T., de Fromentel, C. C. & May, P. Oncogene 5, 945–952 (1990).
Bradley, A. in Tetratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Stutman, O. Fed. Proc. Fed. Am. Soc. exp. Biol. 33, 2028–2032 (1974).
Yandell, D. W. Proc. Am. Assoc. Cancer Res. 32, 459–460 (1991).
Sepulveda, A. R. et al. Cancer Res. 49, 6108–6117 (1989).
Slagle, B. L., Lanford, R. E., Medina, D. & Butel, J. S. Cancer Res. 42, 2155–2162 (1984).

Sorted by citations

Items 501–600 of 1,032

The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers
Zudaire, E., Cuesta, N., Murty, V. V. V. S., Woodson, K. G., Adams, L., Gonzalez, N., Martı́nez, A., Narayan, G., Kirsch, I. R., Franklin, W. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci30024 · Cited by 215
TP53 family members and human cancers
Bénard, J., Douc‐Rasy, S., & Ahomadegbe, J. (2003) · Human Mutation · doi:10.1002/humu.10172 · Cited by 215
Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
Lin, A. W., & Lowe, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091100298 · Cited by 215
Isoform-specific p73 knockout mice reveal a novel role for ΔNp73 in the DNA damage response pathwayPreprint
Wilhelm, M., Rufini, A., Wetzel, M. K., Tsuchihara, K., Inoue, S., Tomasini, R., Itie-YouTen, A., Wakeham, A. C., Arsenian‐Henriksson, M., Melino, G., et al. (2010) · Genes & Development · doi:10.1101/gad.1873910 · Cited by 214
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
Herschkowitz, J. I., Zhao, W., Zhang, M., Usary, J., Murrow, G., Edwards, D., Knezevic, J., Greene, S. B., Darr, D. B., Troester, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018862108 · Cited by 213
Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating oncogene
Stewart, M., Terry, A., Hu, M., O’Hara, M., Blyth, K., Baxter, E. W., Cameron, E. R., Onions, D. E., & Neil, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8646 · Cited by 213
HPV‐associated skin disease
Akgũl, B., Cooke, J. C., & Storey, A. (2005) · The Journal of Pathology · doi:10.1002/path.1893 · Cited by 212
In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
Michalak, E. M., Villunger, A., Adams, J. M., & Strasser, A. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.16 · Cited by 211
Inflammation and p53: A Tale of Two Stresses
Gudkov, A. V., Gurova, K. V., & Komarova, E. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409747 · Cited by 211
Increased Susceptibility of Thymocytes to Apoptosis in Mice Lacking AIM, a Novel Murine Macrophage-derived Soluble Factor Belonging to the Scavenger Receptor Cysteine-rich Domain Superfamily
Miyazaki, T., Hirokami, Y., Matsuhashi, N., Takatsuka, H., & Naito, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.413 · Cited by 210
Tumor suppressor genes
Hinds, P. W., & Weinberg, R. A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90102-3 · Cited by 210
Chronic restraint stress attenuates p53 function and promotes tumorigenesis
Feng, Z., Liu, L., Zhang, C., Zheng, T., Wang, J., Lin, M., Zhao, Y., Wang, X., Levine, A. J., & Hu, W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203930109 · Cited by 209
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
Agah, R., Kirshenbaum, L. A., Abdellatif, M., Truong, L. D., Chakraborty, S., Michael, L. H., & Schneider, M. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119817 · Cited by 209
TP53: a key gene in human cancer
Guimarães, D. P., & Hainaut, P. L. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01356-6 · Cited by 209
Wide spectrum of tumors in knock‐in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
Sotillo, R., Dubus, P., Martn, J., de la Cueva, E., Ortega, S., Malumbres, M., & Barbacid, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6637 · Cited by 208
Stressin’ Sestrins take an aging fight
Budanov, A. V., Lee, J. H., & Karin, M. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000097 · Cited by 208
Mutant p53: it’s not all one and the same
Kennedy, M. C., & Lowe, S. W. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00989-y · Cited by 211
Hypersensitivity to DNA damage leads to increased apoptosis during early mouse developmentPreprint
Heyer, B. S., MacAuley, A., Behrendtsen, O., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.14.16.2072 · Cited by 208
Variation in the human TP53 gene affects old age survival and cancer mortality
van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J. M., Brandt, B. W., Slagboom, P. E., & Westendorp, R. G. J. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.001 · Cited by 207
Stress-Responsive Sestrins Link p53 with Redox Regulation and Mammalian Target of Rapamycin Signaling
Budanov, A. V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3530 · Cited by 208
Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
Vierboom, M., Nijman, H. W., Offringa, R., van der Voort, E. I. H., van Hall, T., van den Broek, L., Fleuren, G. J., Kenemans, P., Kast, W. M., & Melief, C. J. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.695 · Cited by 206
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 205
Genetic Analysis of Circadian Clocks
Dunlap, J. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.003343 · Cited by 205
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.Preprint
Naik, P., Karrim, J., & Hanahan, D. (1996) · Genes & Development · doi:10.1101/gad.10.17.2105 · Cited by 205
Regulation of V(D)J Recombination Activator Protein RAG-2 by Phosphorylation
Lin, W.-C., & Desiderio, S. V. (1993) · Science · doi:10.1126/science.8493533 · Cited by 204
ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.
Moser, A. R., Mattes, E., Dove, W. F., Lindstrom, M. J., Haag, J. D., & Gould, M. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8977 · Cited by 204
A reassessment of the telomere hypothesis of senescence
Reddel, R. R. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199812)20:12 · Cited by 65
Strain difference in establishment of mouse embryonic stem (ES) cell lines
Kawase, E., Suemori, H., Takahashi, N., Okazaki, K., Hashimoto, K., & Nakatsuji, N. (1994) · The International Journal of Developmental Biology · doi:10.1387/ijdb.7981049 · Cited by 203
Cyclin-Dependent Kinase Inhibitor p21 Controls Adult Neural Stem Cell Expansion by Regulating Sox2 Gene Expression
Marqués‐Torrejón, M. Á., Porlan, E., Banito, A., Gómez-Ibarlucea, E., Lopez-Contreras, A. J., Fernández-Capetillo, Ó., Vidal, A., Gil, J., Torres, J., & Fariñas, I. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.12.001 · Cited by 204
Overexpression and mutations of p53 in metastatic malignant melanomas
Hartmann, A., Blaszyk, H., Cunningham, J. S., McGovern, R. M., Jj, S., Helander, S. D., Pittelkow, M. R., Sommer, S. S., & Kovach, J. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3 · Cited by 63
Analyzing the G2/M Checkpoint
Stark, G. R., & Taylor, W. R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:051 · Cited by 203
The role of p53 in tumour suppression: lessons from mouse models
Attardi, L. D., & Jacks, T. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050269 · Cited by 203
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
Jerry, D. J., Kittrell, F. S., Kuperwasser, C., Laucirica, R., Dickinson, E. S., Bonilla, P. J., Butel, J. S., & Medina, D. (2000) · Oncogene · doi:10.1038/sj.onc.1203270 · Cited by 203
Self-citation
Neuronal life and death: an essential role for the p53 family
Miller, F. D., Pozniak, C. D., & Walsh, G. S. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400736 · Cited by 203
CKIα ablation highlights a critical role for p53 in invasiveness control
Elyada, E., Pribluda, A., Goldstein, R. E., Morgenstern, Y., Brachya, G., Cojocaru, G., Snir-Alkalay, I., Burstain, I., Haffner‐Krausz, R., Jung, S., et al. (2011) · Nature · doi:10.1038/nature09673 · Cited by 202
Cancer selection
Leroi, A. M., Koufopanou, V., & Burt, A. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1016 · Cited by 202
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
Frébourg, T., Barbier, N., Yan, Y.-X., Garber, J. E., Dreyfus, M., Fraumeni, J. F., Li, F. P., & Friend, S. H. (1995) · Europe PMC (PubMed Central) · Cited by 202
p53 is a general repressor of RNA polymerase III transcription
Cairns, C. A., & White, R. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3112 · Cited by 202
Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
Pantoja, C., & Serrano, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202880 · Cited by 201
PTP1B: A simple enzyme for a complex world
Feldhammer, M., Uetani, N., Miranda‐Saavedra, D., & Tremblay, M. L. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.819830 · Cited by 201
Bladder cancers arise from distinct urothelial sub-populations
Batavia, J. V., Yamany, T., Molotkov, A., Dan, H., MANSUKHANI, M. M., Batourina, E., Schneider, K., Oyón, D., Dunlop, M., Wu, X., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3038 · Cited by 201
High metastatic potential in mice inheriting a targeted p53 missense mutation
Liu, G., McDonnell, T. J., Luna, R. M. D. O., Kapoor, M., Mims, B. H., El‐Naggar, A. K., & Lozano, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4174 · Cited by 201
Cellular UV damage responses—Functions of tumor suppressor p53
Latonen, L., & Laiho, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.003 · Cited by 200
Translating p53-based therapies for cancer into the clinic
Peuget, S., Zhou, X., & Selivanova, G. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-023-00658-3 · Cited by 208
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
Toledo, F., Krummel, K. A., Lee, C. J., Liu, C.-W., Rodewald, L.-W., Tang, M., & Wahl, G. M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.014 · Cited by 199
Reactive oxygen species: A radical role in development?
Hernández-García, D., Wood, C. D., Castro‐Obregón, S., & Covarrubias, L. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.020 · Cited by 199
Regulation of Notch1 Gene Expression by p53 in Epithelial Cells
Yugawa, T., Handa, K., Narisawa‐Saito, M., Ohno, S.-I., Fujita, M., & Kiyono, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02119-06 · Cited by 199
Loss of cryptochrome reduces cancer risk in p53 mutant mice
Öztürk, N., Lee, J. H., Gaddameedhi, S., & Sancar, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813028106 · Cited by 199
Induction of KLF4 in basal keratinocytes blocks the proliferation–differentiation switch and initiates squamous epithelial dysplasia
Foster, K. W., Liu, Z., Nail, C. D., Li, X., FitzGerald, T. J., Bailey, S. K., Frost, A. R., Louro, I. D., Townes, T. M., Paterson, A. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208307 · Cited by 199
Characterization of Radiation-induced Apoptosis in the Small Intestine and Its Biological Implications
Potten, C. S., Merritt, A. J., Hickman, J. A., Hall, P. A., & Faranda, A. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414550101 · Cited by 199
Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes
Bernerd, F., Sarasin, A. R., & Magnaldo, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11329 · Cited by 199
Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation
Pritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., & Hickman, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1795 · Cited by 199
Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Stegh, A. H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.643299 · Cited by 198
p53: Guardian of ploidy
Aylon, Y., & Oren, M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.007 · Cited by 198
Intact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival
Jackson, D. N., & Foster, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0979rev · Cited by 197
p21 WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential
Topley, G., Okuyama, R., Gonzales, J. G., Conti, C. J., & Dotto, G. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9089 · Cited by 197
A transactivation-deficient mouse model provides insights into Trp53 regulation and function
Jimenez, G. S., Nistér, M., Stommel, J. M., Beeche, M., Barcarse, E. A., Zhang, X.-Q., O’Gorman, S., & Wahl, G. M. (2000) · Nature Genetics · doi:10.1038/79152 · Cited by 197
What to do at an end: DNA double-strand-break repair
Weaver, D. T. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89121-0 · Cited by 197
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 196
Self-citation
Human DNA repair systems: An overview
Yu, Z., Chen, J., Ford, B. N., Brackley, M. E., & Glickman, B. W. (1999) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1999)33:1 · Cited by 195
p53 regulates Period2 expression and the circadian clock
Miki, T., Matsumoto, T., Zhao, Z., & Lee, C. C. (2013) · Nature Communications · doi:10.1038/ncomms3444 · Cited by 195
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2675 · Cited by 195
RETRACTED: 1,25‐Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2‐antioxidant signaling and inactivation of p16/p53‐senescence signaling
Chen, L., Yang, R., Qiao, W., Zhang, W. Y., Chen, J., Mao, L., Goltzman, D., & Miao, D. (2019) · Aging Cell · doi:10.1111/acel.12951 · Cited by 195
Retracted
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
Artandi, S. E., & Attardi, L. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.211 · Cited by 194
Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- γc-/- mice: functional inactivation of p53 in developing T cells
Gimeno, R., Weijer, K. C., Voordouw, A. C., Uíttenbogaart, C. H., Legrand, N., Alves, N. L., Wijnands, E., Blom, B., & Spits, H. (2004) · Blood · doi:10.1182/blood-2004-02-0656 · Cited by 194
p63: molecular complexity in development and cancer
Westfall, M. D. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh148 · Cited by 194
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
Overholtzer, M., Rao, P. H., Favis, R., Lu, X.-Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., & Levine, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934852100 · Cited by 193
ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis
Keyes, W. M., Pecoraro, M., Aranda, V., Vernersson-Lindahl, E., Li, W., Vogel, H., Guo, X., Garcia, E. L., Michurina, T. V., Enikolopov, G., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.009 · Cited by 193
“In contrast to the viable and fertile, yet tumor-prone, phenotype of p53-deficient mice (Donehower et al., 1992; Jacks et al., 1994), p63-deficient mice die postnatally from severe developmental anomalies, including a lack of skin and associated derivatives, an absence of glands such as prostate and breast, and trunca…”
Mice Lacking Pituitary Tumor Transforming Gene Show Testicular and Splenic Hypoplasia, Thymic Hyperplasia, Thrombocytopenia, Aberrant Cell Cycle Progression, and Premature Centromere Division
Wang, Z., Yu, R., & Melmed, S. K. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0729 · Cited by 193
Loss of p53 and centrosome hyperamplification
Tarapore, P., & Fukasawa, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205707 · Cited by 193
Cell Cycle Analysis of p53-Induced Cell Death in Murine Erythroleukemia Cells
Ryan, J. J., Danish, R., Gottlieb, C. A., & Clarke, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.711 · Cited by 193
mdmx is a negative regulator of p53 activity in vivo.
Finch, R. A., Donoviel, D. B., Potter, D., Shi, M., Fan, A., Freed, D. D., Wang, C.-Y., Zambrowicz, B., Ramírez‐Solis, R., Sands, A., et al. (2002) · PubMed · Cited by 192
A molecular fingerprint for medulloblastoma.
Lee, Y., Miller, H. L., Jensen, P., Hernán, R., Connelly, M., Wetmore, C., Zindy, F., Roussel, M. F., Curran, T., Gilbertson, R. J., et al. (2003) · PubMed · Cited by 192
Hypoxia-Inducible Factor-1α Mediates Hypoxia-Induced Delayed Neuronal Death That Involves p53
Halterman, M. W., Miller, C. C., & Federoff, H. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06818.1999 · Cited by 191
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
Bristow, R. G., Benchimol, S., & Hill, R. P. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01806-3 · Cited by 191
Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
Xu-Monette, Z. Y., Medeiros, L. J., Li, Y., Orlowski, R. Z., Andreeff, M., Bueso-Ramos, C., Greiner, T. C., McDonnell, T. J., & Young, K. H. (2012) · Blood · doi:10.1182/blood-2011-11-366062 · Cited by 190
The use of shuttle vectors for mutation analysis in transgenic mice and rats
Dycaico, M. J., Provost, G. S., Kretz, P. L., Ransom, S. L., Moores, J. C., & Short, J. M. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90257-7 · Cited by 190
Activation of the cryptic DNA binding function of mutant forms of p53
Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3167 · Cited by 190
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
Barnes, D. M., Gillett, C. E., Bobrow, L. G., Hanby, A. M., Mohammed, S. N., Hodgson, S. V., Leigh, I. M., Purkis, T., MacGeoch, C., Spurr, N. K., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)92354-i · Cited by 190
Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3
Patton, J. T., Mayo, L. D., Singhi, A. D., Gudkov, A. V., Stark, G. R., & Jackson, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3832 · Cited by 189
Extensive meiotic asynapsis in mice antagonises meiotic silencing of unsynapsed chromatin and consequently disrupts meiotic sex chromosome inactivation
Mahadevaiah, S. K., Bourc’his, D., de Rooij, D. G., Bestor, T. H., Turner, J. M. A., & Burgoyne, P. S. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710195 · Cited by 189
Angiosarcoma of the head and neck
Lydiatt, W. M., Shaha, A. R., & Shah, J. P. (1994) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80097-2 · Cited by 189
The p53 gene and its role in human brain tumors
Bögler, O., Huang, H., Kleihues, P., & Cavenee, W. K. (1995) · Glia · doi:10.1002/glia.440150311 · Cited by 189
Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations
DUESBERG, P. H., & Li, R. (2003) · Cell Cycle · doi:10.4161/cc.2.3.382 · Cited by 189
The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis
Kim, H. L., & Muller, W. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4706 · Cited by 189
p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism
Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 188
Mechanisms of induction of skin cancer by UV radiation
Ananthaswamy, H. N. (1997) · Frontiers in bioscience · doi:10.2741/a211 · Cited by 188
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice
Kuperwasser, C., Hurlbut, G. D., Kittrell, F. S., Dickinson, E. S., Laucirica, R., Medina, D., Naber, S. P., & Jerry, D. J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64853-5 · Cited by 188
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine
Jones, B. A., & Gores, G. J. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.6.g1174 · Cited by 187
Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays
Cai, W., Mao, J., Chow, C.-W., Damani, S., Balmain, A., & Bradley, A. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-393 · Cited by 187
Self-citation
A Common Biological Mechanism in Cancer and Alzheimers Disease?
Behrens, M. I., Lendon, C., & Roe, C. M. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 186
Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle
Saleem, A., Adhihetty, P. J., & Hood, D. A. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90346.2008 · Cited by 185
Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.
Huang, C., Ma, W. Y., Li, J., & Dong, Z. (1999) · PubMed · Cited by 185
The p53 tumour suppressor gene
Steele, R. J., Thompson, A. M., Hall, P. A., & Lane, D. P. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00910.x · Cited by 185
Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages
Prokocimer, M., & Rotter, V. (1994) · Blood · doi:10.1182/blood.v84.8.2391.bloodjournal8482391 · Cited by 185
Temporal dissection of p53 function in vitro and in vivo
Christophorou, M. A., Martı́n-Zanca, D., Soucek, L., Lawlor, E. R., Swigart, L. B., Verschuren, E. W., & Evan, G. I. (2005) · Nature Genetics · doi:10.1038/ng1572 · Cited by 184
Chromatin Regulatory Mechanisms in Pluripotency
Lessard, J. A., & Crabtree, G. R. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-051809-102012 · Cited by 185
ATR signaling can drive cells into senescence in the absence of DNA breaks
Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R., & Fernandez-Capetillo, O. (2008) · Genes & Development · doi:10.1101/gad.452308 · Cited by 183

Authors: Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A.
Affiliations: Baylor College of Medicine (US)
ORCID: Slagle, Betty L.
Butel, Janet S.
Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1992-03
Volume: 356
Issue: 6366
Pages: 215-221
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/356215a0
OpenAlex: W2126679757
Cited by: 4,649
References: 48
Citations by year: 2026: 16 · 2025: 48 · 2024: 51 · 2023: 74 · 2022: 76 · 2021: 80 · 2020: 86 · 2019: 92 · 2018: 84 · 2017: 96 · 2016: 119 · 2015: 89 · 2014: 121 · 2013: 146 · 2012: 157
FWCI: 82.13
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, spontaneous tumors, carcinogenesis, embryonic development, mouse model, neoplasms
MeSH terms: Alleles, Animals, Base Sequence, Blastocyst, DNA, Exons, Female, Genetic Vectors, Heterozygote, Homozygote, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mutation, Neoplasms, Experimental, RNA, Messenger, Stem Cells, Blotting, Southern, Polymerase Chain Reaction, Genes, p53, Tumor Suppressor Protein p53, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks